The artificial intelligence (ai) electrocardiogram (ecg) analysis market size has grown rapidly in recent years. It will grow from $2.01 billion in 2025 to $2.4 billion in 2026 at a compound annual growth rate (CAGR) of 19.3%. The growth in the historic period can be attributed to limited availability of ai-based ecg analysis tools, manual ecg interpretation practices, growing prevalence of cardiac disorders, rising healthcare digitization, reliance on hospital-based ecg systems.
The artificial intelligence (ai) electrocardiogram (ecg) analysis market size is expected to see rapid growth in the next few years. It will grow to $4.81 billion in 2030 at a compound annual growth rate (CAGR) of 19%. The growth in the forecast period can be attributed to advancements in deep learning algorithms for ecg, increasing adoption of wearable and portable ecg devices, expansion of telehealth and remote monitoring, growing investment in cloud-based healthcare solutions, regulatory approvals for ai-assisted diagnostic tools. Major trends in the forecast period include increasing adoption of ai-driven ecg analysis in hospitals, integration of wearable ecg monitoring devices with ai platforms, rising demand for remote ecg monitoring and telecardiology services, focus on real-time cardiac data visualization and decision support, expansion of cloud-based ecg analysis solutions.
The growing burden of cardiovascular diseases is anticipated to drive the expansion of the AI-powered electrocardiogram (ECG) analysis market in the coming years. Cardiovascular diseases encompass conditions that affect the heart and blood vessels, such as coronary heart disease, heart failure, stroke, and hypertension. The rising incidence of these diseases is attributed to factors including aging populations, metabolic risks, unhealthy dietary habits, and sedentary lifestyles, all of which increase the likelihood of heart-related complications. AI-powered ECG analysis supports healthcare systems by facilitating early identification of cardiac abnormalities, optimizing diagnostic workflows, and enhancing clinical decision-making to improve patient outcomes. For instance, in October 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, cardiovascular diseases accounted for 919,032 deaths in 2023, representing one in every three deaths. Coronary heart disease continued to be the most common type of heart disease, and notably, approximately one in six cardiovascular-related deaths occurred among adults under the age of 65. As a result, the increasing prevalence of cardiovascular diseases is accelerating the adoption of AI-powered ECG analysis solutions.
Leading companies in this market are developing advanced solutions such as AI marketplaces to streamline cardiac diagnostics and enhance clinical workflows. AI marketplaces are centralized platforms that provide access to multiple validated AI diagnostic tools, allowing healthcare providers to integrate sophisticated algorithms into clinical systems for faster and more accurate diagnoses. For instance, in July 2025, Koninklijke Philips N.V., a Netherlands-based health technology company, launched Philips’ ECG AI marketplace. This platform integrates AI-powered diagnostic tools into IntelliSpace ECG and cardiograph systems, featuring FDA-cleared algorithms like Anumana’s low ejection fraction AI ECG algorithm. The marketplace accelerates ECG review, enables earlier detection of heart failure using standard 12-lead resting ECGs, and improves both clinical efficiency and diagnostic accuracy.
In June 2024, AI/ML Innovations Inc., a Canada-based healthcare company specializing in artificial intelligence and machine learning solutions, acquired proprietary neural network technology from Naiad Lab Inc. for an undisclosed sum. This acquisition is intended to strengthen AI/ML Innovations’ cardiovascular analytics offerings by incorporating Naiad Lab’s Long ECG Neural Net, which enables precise beat-by-beat ECG classification across long-duration recordings, along with the Neural Network Store (NNStore), a subscription-driven platform for AI-powered ECG analysis. Naiad Lab Inc. is a Canada-based firm known for developing advanced neural network architectures for ECG signal analysis and cardiovascular intelligence.
Major companies operating in the artificial intelligence (ai) electrocardiogram (ecg) analysis market are iRhythm Technologies Inc., Viz.ai Inc., Tempus Labs Inc., HeartSciences Inc., Neurosoft Software Production S.A., Tricog Health Services Pvt. Ltd., Anumana Inc., IDOVEN S.L., Ultromics Limited., VUNO Inc., Cardio.AI Inc., Powerful Medical s.r.o., RSIP Vision Ltd., AccurKardia Inc., Cardiologs Technologies SAS, Cardiomatics Sp. z o.o., Cordys Analytics B.V., PulseAI Ltd., Vektor Medical Inc., DeepECG Inc.
North America was the largest region in the artificial intelligence (AI) electrocardiogram (ECG) analysis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) electrocardiogram (ecg) analysis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the artificial intelligence (AI) electrocardiogram (ecg) analysis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the ai ecg analysis market by increasing the cost of imported hardware, wearable devices, and cloud infrastructure components, which has raised overall deployment expenses. Segments such as portable ecg units and sensor-integrated wearable devices are most impacted, particularly in regions like North America and Asia-Pacific where imports are significant. Despite cost pressures, tariffs have incentivized local manufacturing and innovation in ai-enabled ecg technologies, leading to more competitive domestic solutions and enhanced supply chain resilience.
The artificial intelligence (AI) electrocardiogram (ecg) analysis market research report is one of a series of new reports that provides artificial intelligence (AI) electrocardiogram (ecg) analysis market statistics, including artificial intelligence (AI) electrocardiogram (ecg) analysis industry global market size, regional shares, competitors with a artificial intelligence (AI) electrocardiogram (ecg) analysis market share, detailed artificial intelligence (AI) electrocardiogram (ecg) analysis market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI) electrocardiogram (ecg) analysis industry. This artificial intelligence (AI) electrocardiogram (ecg) analysis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Artificial intelligence (AI) electrocardiogram (ECG) analysis refers to the use of machine learning and deep learning algorithms to automatically interpret ECG signals. It facilitates rapid and accurate detection of cardiac abnormalities, improves diagnostic precision, reduces human error, and supports timely clinical decision-making.
The main components of AI ECG analysis include software, hardware, and services. AI ECG analysis software consists of advanced digital solutions that employ AI algorithms to automatically interpret ECG data, enabling efficient and accurate detection of cardiac abnormalities. These solutions are available in on-premises and cloud-based formats. They are commonly used to detect and monitor conditions such as cardiac arrhythmias, heart failure, ischemic heart disease, and coronary artery disease, with applications in hospitals, clinics, and other healthcare settings.
The artificial intelligence (AI) electrocardiogram (ECG) analysis market consists of revenues earned by entities by providing services such as algorithm customization, real-time electrocardiogram data interpretation, artificial intelligence (AI)-based risk stratification, automated electrocardiogram reporting, and predictive cardiac event alerts. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence electrocardiogram analysis market also includes sales of machine learning engines, artificial intelligence-integrated diagnostic dashboards, electrocardiogram signal processing modules, wearable-compatible analysis chips, and mobile electrocardiogram data viewers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The artificial intelligence (ai) electrocardiogram (ecg) analysis market size is expected to see rapid growth in the next few years. It will grow to $4.81 billion in 2030 at a compound annual growth rate (CAGR) of 19%. The growth in the forecast period can be attributed to advancements in deep learning algorithms for ecg, increasing adoption of wearable and portable ecg devices, expansion of telehealth and remote monitoring, growing investment in cloud-based healthcare solutions, regulatory approvals for ai-assisted diagnostic tools. Major trends in the forecast period include increasing adoption of ai-driven ecg analysis in hospitals, integration of wearable ecg monitoring devices with ai platforms, rising demand for remote ecg monitoring and telecardiology services, focus on real-time cardiac data visualization and decision support, expansion of cloud-based ecg analysis solutions.
The growing burden of cardiovascular diseases is anticipated to drive the expansion of the AI-powered electrocardiogram (ECG) analysis market in the coming years. Cardiovascular diseases encompass conditions that affect the heart and blood vessels, such as coronary heart disease, heart failure, stroke, and hypertension. The rising incidence of these diseases is attributed to factors including aging populations, metabolic risks, unhealthy dietary habits, and sedentary lifestyles, all of which increase the likelihood of heart-related complications. AI-powered ECG analysis supports healthcare systems by facilitating early identification of cardiac abnormalities, optimizing diagnostic workflows, and enhancing clinical decision-making to improve patient outcomes. For instance, in October 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, cardiovascular diseases accounted for 919,032 deaths in 2023, representing one in every three deaths. Coronary heart disease continued to be the most common type of heart disease, and notably, approximately one in six cardiovascular-related deaths occurred among adults under the age of 65. As a result, the increasing prevalence of cardiovascular diseases is accelerating the adoption of AI-powered ECG analysis solutions.
Leading companies in this market are developing advanced solutions such as AI marketplaces to streamline cardiac diagnostics and enhance clinical workflows. AI marketplaces are centralized platforms that provide access to multiple validated AI diagnostic tools, allowing healthcare providers to integrate sophisticated algorithms into clinical systems for faster and more accurate diagnoses. For instance, in July 2025, Koninklijke Philips N.V., a Netherlands-based health technology company, launched Philips’ ECG AI marketplace. This platform integrates AI-powered diagnostic tools into IntelliSpace ECG and cardiograph systems, featuring FDA-cleared algorithms like Anumana’s low ejection fraction AI ECG algorithm. The marketplace accelerates ECG review, enables earlier detection of heart failure using standard 12-lead resting ECGs, and improves both clinical efficiency and diagnostic accuracy.
In June 2024, AI/ML Innovations Inc., a Canada-based healthcare company specializing in artificial intelligence and machine learning solutions, acquired proprietary neural network technology from Naiad Lab Inc. for an undisclosed sum. This acquisition is intended to strengthen AI/ML Innovations’ cardiovascular analytics offerings by incorporating Naiad Lab’s Long ECG Neural Net, which enables precise beat-by-beat ECG classification across long-duration recordings, along with the Neural Network Store (NNStore), a subscription-driven platform for AI-powered ECG analysis. Naiad Lab Inc. is a Canada-based firm known for developing advanced neural network architectures for ECG signal analysis and cardiovascular intelligence.
Major companies operating in the artificial intelligence (ai) electrocardiogram (ecg) analysis market are iRhythm Technologies Inc., Viz.ai Inc., Tempus Labs Inc., HeartSciences Inc., Neurosoft Software Production S.A., Tricog Health Services Pvt. Ltd., Anumana Inc., IDOVEN S.L., Ultromics Limited., VUNO Inc., Cardio.AI Inc., Powerful Medical s.r.o., RSIP Vision Ltd., AccurKardia Inc., Cardiologs Technologies SAS, Cardiomatics Sp. z o.o., Cordys Analytics B.V., PulseAI Ltd., Vektor Medical Inc., DeepECG Inc.
North America was the largest region in the artificial intelligence (AI) electrocardiogram (ECG) analysis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) electrocardiogram (ecg) analysis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the artificial intelligence (AI) electrocardiogram (ecg) analysis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the ai ecg analysis market by increasing the cost of imported hardware, wearable devices, and cloud infrastructure components, which has raised overall deployment expenses. Segments such as portable ecg units and sensor-integrated wearable devices are most impacted, particularly in regions like North America and Asia-Pacific where imports are significant. Despite cost pressures, tariffs have incentivized local manufacturing and innovation in ai-enabled ecg technologies, leading to more competitive domestic solutions and enhanced supply chain resilience.
The artificial intelligence (AI) electrocardiogram (ecg) analysis market research report is one of a series of new reports that provides artificial intelligence (AI) electrocardiogram (ecg) analysis market statistics, including artificial intelligence (AI) electrocardiogram (ecg) analysis industry global market size, regional shares, competitors with a artificial intelligence (AI) electrocardiogram (ecg) analysis market share, detailed artificial intelligence (AI) electrocardiogram (ecg) analysis market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI) electrocardiogram (ecg) analysis industry. This artificial intelligence (AI) electrocardiogram (ecg) analysis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Artificial intelligence (AI) electrocardiogram (ECG) analysis refers to the use of machine learning and deep learning algorithms to automatically interpret ECG signals. It facilitates rapid and accurate detection of cardiac abnormalities, improves diagnostic precision, reduces human error, and supports timely clinical decision-making.
The main components of AI ECG analysis include software, hardware, and services. AI ECG analysis software consists of advanced digital solutions that employ AI algorithms to automatically interpret ECG data, enabling efficient and accurate detection of cardiac abnormalities. These solutions are available in on-premises and cloud-based formats. They are commonly used to detect and monitor conditions such as cardiac arrhythmias, heart failure, ischemic heart disease, and coronary artery disease, with applications in hospitals, clinics, and other healthcare settings.
The artificial intelligence (AI) electrocardiogram (ECG) analysis market consists of revenues earned by entities by providing services such as algorithm customization, real-time electrocardiogram data interpretation, artificial intelligence (AI)-based risk stratification, automated electrocardiogram reporting, and predictive cardiac event alerts. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence electrocardiogram analysis market also includes sales of machine learning engines, artificial intelligence-integrated diagnostic dashboards, electrocardiogram signal processing modules, wearable-compatible analysis chips, and mobile electrocardiogram data viewers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Artificial Intelligence (AI) Electrocardiogram (ECG) Analysis Market Characteristics
3. Artificial Intelligence (AI) Electrocardiogram (ECG) Analysis Market Supply Chain Analysis
4. Global Artificial Intelligence (AI) Electrocardiogram (ECG) Analysis Market Trends and Strategies
5. Artificial Intelligence (AI) Electrocardiogram (ECG) Analysis Market Analysis of End Use Industries
7. Global Artificial Intelligence (AI) Electrocardiogram (ECG) Analysis Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Artificial Intelligence (AI) Electrocardiogram (ECG) Analysis Total Addressable Market (TAM) Analysis for the Market
9. Artificial Intelligence (AI) Electrocardiogram (ECG) Analysis Market Segmentation
10. Artificial Intelligence (AI) Electrocardiogram (ECG) Analysis Market Regional and Country Analysis
11. Asia-Pacific Artificial Intelligence (AI) Electrocardiogram (ECG) Analysis Market
12. China Artificial Intelligence (AI) Electrocardiogram (ECG) Analysis Market
13. India Artificial Intelligence (AI) Electrocardiogram (ECG) Analysis Market
14. Japan Artificial Intelligence (AI) Electrocardiogram (ECG) Analysis Market
15. Australia Artificial Intelligence (AI) Electrocardiogram (ECG) Analysis Market
16. Indonesia Artificial Intelligence (AI) Electrocardiogram (ECG) Analysis Market
17. South Korea Artificial Intelligence (AI) Electrocardiogram (ECG) Analysis Market
18. Taiwan Artificial Intelligence (AI) Electrocardiogram (ECG) Analysis Market
19. South East Asia Artificial Intelligence (AI) Electrocardiogram (ECG) Analysis Market
20. Western Europe Artificial Intelligence (AI) Electrocardiogram (ECG) Analysis Market
21. UK Artificial Intelligence (AI) Electrocardiogram (ECG) Analysis Market
22. Germany Artificial Intelligence (AI) Electrocardiogram (ECG) Analysis Market
23. France Artificial Intelligence (AI) Electrocardiogram (ECG) Analysis Market
24. Italy Artificial Intelligence (AI) Electrocardiogram (ECG) Analysis Market
25. Spain Artificial Intelligence (AI) Electrocardiogram (ECG) Analysis Market
26. Eastern Europe Artificial Intelligence (AI) Electrocardiogram (ECG) Analysis Market
27. Russia Artificial Intelligence (AI) Electrocardiogram (ECG) Analysis Market
28. North America Artificial Intelligence (AI) Electrocardiogram (ECG) Analysis Market
29. USA Artificial Intelligence (AI) Electrocardiogram (ECG) Analysis Market
30. Canada Artificial Intelligence (AI) Electrocardiogram (ECG) Analysis Market
31. South America Artificial Intelligence (AI) Electrocardiogram (ECG) Analysis Market
32. Brazil Artificial Intelligence (AI) Electrocardiogram (ECG) Analysis Market
33. Middle East Artificial Intelligence (AI) Electrocardiogram (ECG) Analysis Market
34. Africa Artificial Intelligence (AI) Electrocardiogram (ECG) Analysis Market
36. Artificial Intelligence (AI) Electrocardiogram (ECG) Analysis Market Competitive Landscape and Company Profiles
37. Artificial Intelligence (AI) Electrocardiogram (ECG) Analysis Market Other Major and Innovative Companies
40. Artificial Intelligence (AI) Electrocardiogram (ECG) Analysis Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Artificial Intelligence (AI) Electrocardiogram (ECG) Analysis Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses artificial intelligence (ai) electrocardiogram (ecg) analysis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for artificial intelligence (ai) electrocardiogram (ecg) analysis? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence (ai) electrocardiogram (ecg) analysis market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Component: Software; Hardware; Services2) By Type: On-Premise; Cloud-Based
3) By Medical Condition: Cardiac Arrhythmias; Heart Failure; Ischemic Heart Disease And Coronary Artery Disease
4) By Application: Hospital; Clinic; Other Applications
Subsegments:
1) By Software: Artificial Intelligence Electrocardiogram (ECG) Interpretation Platforms; Machine Learning-Based Electrocardiogram Diagnostic Tools; Deep Learning Electrocardiogram (ECG) Analysis Software; Cloud-Based Electrocardiogram Analysis Systems; Real-Time Electrocardiogram Data Visualization Software2) By Hardware: Wearable Electrocardiogram Monitoring Devices; Portable Electrocardiogram Acquisition Units; Smart Electrocardiogram Patches; Multi-Lead Electrocardiogram Recording Machines; Sensor-Integrated Electrocardiogram Devices
3) By Services: Remote Electrocardiogram Monitoring Services; Electrocardiogram Data Annotation And Labeling Services; Artificial Intelligence Algorithm Training And Validation For Electrocardiogram; Technical Support And Software Integration For Electrocardiogram; Clinical Electrocardiogram Reporting And Interpretation Services
Companies Mentioned: iRhythm Technologies Inc.; Viz.ai Inc.; Tempus Labs Inc.; HeartSciences Inc.; Neurosoft Software Production S.A.; Tricog Health Services Pvt. Ltd.; Anumana Inc.; IDOVEN S.L.; Ultromics Limited.; VUNO Inc.; Cardio.AI Inc.; Powerful Medical s.r.o.; RSIP Vision Ltd.; AccurKardia Inc.; Cardiologs Technologies SAS; Cardiomatics Sp. z o.o.; Cordys Analytics B.V.; PulseAI Ltd.; Vektor Medical Inc.; DeepECG Inc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this AI Electrocardiogram (ECG) Analysis market report include:- iRhythm Technologies Inc.
- Viz.ai Inc.
- Tempus Labs Inc.
- HeartSciences Inc.
- Neurosoft Software Production S.A.
- Tricog Health Services Pvt. Ltd.
- Anumana Inc.
- IDOVEN S.L.
- Ultromics Limited.
- VUNO Inc.
- Cardio.AI Inc.
- Powerful Medical s.r.o.
- RSIP Vision Ltd.
- AccurKardia Inc.
- Cardiologs Technologies SAS
- Cardiomatics Sp. z o.o.
- Cordys Analytics B.V.
- PulseAI Ltd.
- Vektor Medical Inc.
- DeepECG Inc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 2.4 Billion |
| Forecasted Market Value ( USD | $ 4.81 Billion |
| Compound Annual Growth Rate | 19.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
